2025 · 2nd Quarter (Apr 1 - June 30)

ALLIANCE FOR REGENERATIVE MEDICINE

Filed by AVENUE SOLUTIONS.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2025
Income: $50,000.00
Expenses: Not reported
Registrant: AVENUE SOLUTIONS
Client: ALLIANCE FOR REGENERATIVE MEDICINE
Filing UUID: 163e581c-8fbc-4e06-8d93-a3b041f2dc37
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

H.R. 1509/S.752, Accelerating Kids Access to Care Act; H.R. 1262/S. 932, Give Kids a Chance Act; S. 1637, MVP Act of 2025; Pediatric Review Voucher (PRV) reauthorization; Issues related to Medicaid value based payments; Issues related to cell and gene therapy; Issues related to regulation of, access to, and reimbursement for regenerative medicine companies and products

Literal federal measure citations: H.R. 1509, S.752, H.R. 1262, S. 932, S. 1637

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.